Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,20274,819,0.99 [0.92-1.07],0.8235352594727373
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19657,240,1.06 [0.92-1.23],0.4395507759012247
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22483,139,1.04 [0.86-1.25],0.7027023210916996
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15161,813,1.06 [0.98-1.16],0.1526783567978035
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22442,98,1.04 [0.83-1.29],0.7505862323502247
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20377,92,1.05 [0.83-1.32],0.6950172972391759
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23494,97,1.05 [0.84-1.31],0.6627719846015645
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23510,67,0.96 [0.73-1.26],0.7664602698981997
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19943,50,1.27 [0.94-1.71],0.1263091736093169
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22500,119,1.04 [0.85-1.27],0.7349232168730058
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22466,85,0.95 [0.74-1.21],0.659180293729194
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23591,57,1.11 [0.84-1.48],0.4599381161557518
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23612,65,1.12 [0.86-1.46],0.3889305304294804
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23604,57,1.18 [0.90-1.57],0.2359046414097002
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23262,42,1.02 [0.72-1.43],0.9278305097851892
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22330,392,0.95 [0.85-1.07],0.4231038943029097
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22086,148,0.93 [0.78-1.12],0.4682314903288702
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22209,271,0.93 [0.81-1.06],0.2850077276628692
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",18442,80,0.94 [0.73-1.22],0.650819429422268
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18412,50,1.09 [0.80-1.49],0.5854049415630462
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18634,272,1.06 [0.92-1.21],0.4210804199513693
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18643,281,1.06 [0.92-1.21],0.4208631015292883
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18596,234,0.98 [0.85-1.14],0.7966433069704374
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18417,55,0.88 [0.65-1.19],0.3953771543740446
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20949,555,1.07 [0.97-1.17],0.1769548254669368
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22097,376,0.99 [0.88-1.11],0.8201830712322166
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23006,125,0.90 [0.74-1.10],0.318312917982415
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23650,132,0.98 [0.81-1.19],0.8530966494875505
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23312,76,0.95 [0.74-1.23],0.7137581260927495
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23666,66,1.28 [0.98-1.66],0.0709439112243297
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Stomach,23714,48,1.08 [0.79-1.49],0.6176686275718493
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23393,322,0.95 [0.84-1.08],0.4168100628564952
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23680,108,0.88 [0.71-1.09],0.2491296515818424
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23689,75,0.87 [0.67-1.13],0.3064770956227383
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23633,34,nan [nan-nan],
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma, any site",23636,34,nan [nan-nan],
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi,23563,130,1.09 [0.90-1.32],0.375605739171222
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23695,54,1.15 [0.86-1.53],0.3565080152446204
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Other benign neoplasms of skin,23596,136,0.88 [0.73-1.07],0.1906106288963359
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22510,123,1.18 [0.96-1.43],0.1082818347137848
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22139,255,1.08 [0.94-1.24],0.2680688340157272
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22139,255,1.08 [0.94-1.24],0.2680688340157272
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19918,509,1.06 [0.96-1.17],0.2859398053297914
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23184,39,0.81 [0.56-1.15],0.2344095637473607
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23453,61,1.01 [0.76-1.34],0.9484233480300956
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18534,1441,0.98 [0.92-1.04],0.5164246380535558
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22994,180,1.18 [1.00-1.38],0.0516500319163623
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,20934,151,1.14 [0.95-1.36],0.1526192304478877
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22345,166,1.04 [0.87-1.24],0.647729671505999
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20918,135,1.05 [0.87-1.28],0.5872171189517488
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,21484,701,1.02 [0.93-1.12],0.6325145093174444
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21458,675,1.01 [0.92-1.10],0.8913597546608687
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21953,173,0.81 [0.67-1.00],0.0452098962415462
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21953,172,0.82 [0.67-1.00],0.0488360336545166
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,18384,1291,0.96 [0.90-1.02],0.2093474191478528
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17272,179,0.91 [0.76-1.08],0.2601424147301063
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,18284,1191,0.97 [0.90-1.04],0.3284289188779158
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17142,49,1.36 [1.00-1.84],0.0483726195600369
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17191,98,0.95 [0.75-1.19],0.6483551511104529
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Any mental disorder,20116,687,1.02 [0.93-1.11],0.6907413650326713
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19764,335,1.01 [0.89-1.15],0.8742290284158947
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23144,257,1.04 [0.90-1.20],0.5776351412245397
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23235,199,1.11 [0.95-1.30],0.1947527799609051
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21613,75,0.87 [0.67-1.13],0.2989370359365086
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23569,75,0.88 [0.68-1.13],0.3157816768265142
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19504,75,0.86 [0.66-1.12],0.2548574836248016
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Alcohol dependence,21653,115,0.92 [0.74-1.14],0.4484764320543387
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Smoking dependency,21648,84,1.15 [0.90-1.46],0.2562197887095534
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19494,65,0.91 [0.69-1.20],0.5056127390674654
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19697,268,1.06 [0.93-1.22],0.3606207849116026
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Depression,22519,229,1.06 [0.92-1.23],0.4129890234544519
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Depression or dysthymia,19405,196,1.02 [0.87-1.20],0.7604092849612623
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19534,105,0.91 [0.73-1.14],0.4081070823124493
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Other anxiety disorders,22723,55,0.92 [0.68-1.24],0.5862875125986755
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Neurological diseases,20067,1315,1.01 [0.95-1.08],0.7062555438350094
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18061,81,0.96 [0.76-1.23],0.7749527585828255
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23613,57,0.99 [0.74-1.32],0.9255161696113297
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22365,542,1.00 [0.91-1.10],0.9775706537954812
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Epilepsy,21988,165,0.80 [0.67-0.95],0.0125422203542027
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Migraine,21856,33,1.04 [0.71-1.51],0.85505507468217
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23556,27,1.07 [0.70-1.61],0.7653915957322533
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22744,99,0.96 [0.78-1.19],0.7265200324235244
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22062,239,1.12 [0.97-1.30],0.1175240974433497
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,22979,188,1.08 [0.92-1.27],0.3525368650114325
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22760,473,1.09 [0.99-1.21],0.0899234928701418
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22408,121,1.09 [0.89-1.33],0.3952866280928966
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22509,222,1.08 [0.93-1.25],0.3397817224986138
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23369,89,0.96 [0.76-1.22],0.7625046638881067
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Hemiplegia,23338,58,0.99 [0.74-1.33],0.9720595392446072
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23214,120,0.89 [0.72-1.09],0.2503644957829504
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23120,304,0.97 [0.85-1.10],0.6237312323610671
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22990,174,1.02 [0.86-1.20],0.8423557863256615
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22894,78,0.91 [0.71-1.17],0.4695902236626368
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22921,105,0.99 [0.80-1.23],0.9552927613462372
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22864,48,1.04 [0.75-1.43],0.8239479297228701
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20725,144,1.07 [0.89-1.30],0.4540027167606331
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20964,383,1.07 [0.96-1.20],0.236318502985052
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22745,254,1.22 [1.06-1.39],0.0049537065034496
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23310,71,1.47 [1.14-1.90],0.0027402795589347
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2595,71,1.44 [1.11-1.86],0.0062402157478309
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20786,71,1.47 [1.14-1.89],0.0030941788855664
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23058,99,0.87 [0.69-1.09],0.221797985911497
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23012,53,0.93 [0.68-1.27],0.6340149797255373
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23164,79,0.83 [0.64-1.07],0.1426875971697127
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23187,90,0.84 [0.66-1.07],0.1552455115572291
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23621,138,0.95 [0.79-1.15],0.6049366800155727
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22761,97,0.97 [0.77-1.21],0.780709713845877
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15996,3767,0.95 [0.90-0.99],0.0235602925014415
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23007,61,0.78 [0.58-1.05],0.098066490259131
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16890,2464,1.00 [0.95-1.05],0.9450544554147884
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertension,16936,2510,1.00 [0.95-1.06],0.9432753283239972
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14538,112,1.07 [0.86-1.32],0.5544728612943215
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20997,1675,0.91 [0.86-0.97],0.0026408562474246
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,20258,936,0.88 [0.82-0.96],0.0019235287973367
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22277,338,1.03 [0.92-1.17],0.5838403766533478
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22675,736,0.95 [0.87-1.04],0.251462267460847
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23512,164,0.90 [0.75-1.08],0.2510161759241351
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19825,503,0.90 [0.81-0.99],0.0359732861223623
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20729,1430,0.92 [0.87-0.98],0.0142066168953033
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22843,121,0.96 [0.78-1.18],0.6876883837331098
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22948,240,0.99 [0.86-1.15],0.934856087002506
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22805,83,0.99 [0.77-1.26],0.9328274563400304
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22807,85,1.01 [0.79-1.28],0.9647254679308572
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14505,79,1.01 [0.79-1.30],0.9247840852060908
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18520,78,0.98 [0.76-1.27],0.8982641106452178
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,18612,170,0.80 [0.67-0.96],0.0149455461659058
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11702,134,0.81 [0.66-0.99],0.037024486030895
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,12173,605,0.84 [0.76-0.93],0.0005791821233274
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,18527,85,1.03 [0.81-1.31],0.8188871364068874
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18569,127,0.69 [0.56-0.85],0.0004237009557871
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22405,312,0.96 [0.84-1.09],0.5507779271813021
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22678,182,1.08 [0.92-1.28],0.3404015258304069
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22706,164,1.08 [0.91-1.28],0.3871950485695038
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22793,148,1.11 [0.92-1.33],0.268747865603377
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22315,88,0.91 [0.72-1.16],0.4514288568679693
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22375,148,1.10 [0.92-1.32],0.3103963391674347
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22377,149,1.07 [0.89-1.28],0.4715072866738325
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22362,134,1.06 [0.87-1.28],0.5551596084275883
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23480,127,1.08 [0.89-1.31],0.4478328088279785
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Varicose veins,22568,340,0.96 [0.85-1.08],0.5169802954877722
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypotension,22436,81,0.94 [0.74-1.21],0.6514216202181631
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18471,2009,1.03 [0.98-1.09],0.2425600767172506
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23542,88,1.14 [0.91-1.44],0.2481354979941434
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,21585,245,1.07 [0.93-1.23],0.3588870046133212
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",21549,209,1.06 [0.91-1.24],0.4272936561197653
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22732,272,1.00 [0.88-1.15],0.955885511415124
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22729,269,1.00 [0.87-1.14],0.9589579281771442
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22865,654,0.99 [0.91-1.08],0.8970301814773198
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22284,73,0.95 [0.73-1.23],0.7007769385339335
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Nasal polyp,22377,166,1.09 [0.92-1.29],0.3234223422254108
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22638,427,1.00 [0.90-1.12],0.9733644877920756
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22439,228,1.01 [0.87-1.17],0.9044758317029572
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10267,60,0.94 [0.70-1.25],0.6509346993497017
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21186,856,1.07 [0.99-1.15],0.095507694616807
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Early onset COPD,22406,192,0.99 [0.84-1.17],0.9360329155364572
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22437,223,1.05 [0.90-1.23],0.5080768198614369
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",22437,223,1.05 [0.90-1.23],0.5080768198614369
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22303,669,1.07 [0.98-1.17],0.1095076385249318
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Asthma,16113,669,1.08 [0.99-1.18],0.0873709295126327
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15770,669,1.08 [0.99-1.17],0.0980653950881437
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16103,659,1.08 [0.99-1.18],0.0881417368186171
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23281,97,0.93 [0.74-1.17],0.524647589988968
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22545,77,0.98 [0.76-1.27],0.8860544392230985
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23363,77,0.98 [0.76-1.27],0.8915004729732123
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22538,70,0.90 [0.68-1.18],0.4344316674607429
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural effusion,21391,134,0.92 [0.76-1.12],0.4141206781456006
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,21541,284,1.01 [0.88-1.15],0.9401102646832424
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22345,123,1.14 [0.93-1.39],0.2013718114349925
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15787,5602,0.99 [0.95-1.03],0.5951643492331212
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23223,363,0.99 [0.89-1.12],0.9273949583086052
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23687,78,1.07 [0.84-1.37],0.580852387456164
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Impacted teeth,23690,75,1.10 [0.86-1.41],0.4617707089442081
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Dental caries,22968,108,1.11 [0.90-1.36],0.3442640672825502
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22940,80,0.99 [0.78-1.27],0.9456123795309224
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23677,87,1.06 [0.84-1.34],0.6080751068716892
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22935,75,0.79 [0.61-1.02],0.0735307113778082
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22706,76,1.02 [0.79-1.31],0.8750191202385623
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23618,55,0.96 [0.71-1.29],0.7798627043700169
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18141,326,1.04 [0.91-1.17],0.5780377315700329
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19815,2000,0.98 [0.93-1.03],0.3526642773853525
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophagitis,18203,388,0.98 [0.88-1.10],0.7549504530393707
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18462,647,0.94 [0.86-1.03],0.2060857376912608
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,17887,72,1.00 [0.77-1.30],0.992511833502146
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18094,279,1.01 [0.88-1.16],0.8756146900972344
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17890,75,1.08 [0.84-1.40],0.5386767380435257
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,17975,160,1.02 [0.85-1.22],0.8370258685310268
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17988,173,1.07 [0.91-1.27],0.402471937803912
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23524,118,1.10 [0.90-1.34],0.3707755466654454
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,17930,115,0.84 [0.68-1.04],0.1064528216324165
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18597,782,0.97 [0.89-1.05],0.4375591214950334
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23562,104,1.01 [0.82-1.25],0.9107956904324168
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18106,291,1.00 [0.88-1.14],0.9636590746398284
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17971,156,0.85 [0.71-1.02],0.0777212160105715
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23511,169,0.88 [0.74-1.04],0.1437673654097245
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23542,84,1.01 [0.80-1.28],0.9260823616857596
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Hernia,20202,2053,1.02 [0.97-1.08],0.4065457582578263
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,19271,1122,1.00 [0.94-1.08],0.900080639635139
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,18335,186,0.90 [0.76-1.07],0.2198468373655118
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ventral hernia,18243,94,0.91 [0.72-1.15],0.444866485903542
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18923,774,1.09 [1.00-1.18],0.0466669165205756
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22845,599,1.04 [0.95-1.14],0.4396755819826041
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,18294,1811,0.95 [0.90-1.01],0.1066863262834314
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23378,55,1.10 [0.82-1.46],0.5399710447027559
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23643,70,1.17 [0.91-1.51],0.2256098667652875
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn disease,22316,70,1.17 [0.91-1.51],0.2193170368969359
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22301,55,1.20 [0.90-1.59],0.2207407730722683
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23583,140,0.95 [0.79-1.15],0.5973276835058412
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22386,140,0.95 [0.79-1.15],0.6179082298116403
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22372,126,0.99 [0.81-1.21],0.9254385781270142
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22699,453,1.02 [0.92-1.13],0.6973332870521854
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22696,450,1.03 [0.92-1.14],0.6382849090583771
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16577,94,1.13 [0.90-1.42],0.2786967988028204
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal stricture,23258,94,1.15 [0.92-1.44],0.2264288471178157
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16549,66,1.20 [0.92-1.58],0.1764314584952971
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17022,539,1.01 [0.91-1.11],0.8670374374405806
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16569,86,0.98 [0.77-1.24],0.8559788128956389
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16668,185,1.01 [0.85-1.19],0.9468473165540368
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Constipation,22136,169,0.99 [0.83-1.18],0.9137620176172389
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23325,52,1.08 [0.80-1.47],0.6116838363047448
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16644,161,0.88 [0.74-1.05],0.1629964514889008
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16576,93,1.05 [0.83-1.32],0.6812783630770597
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17347,864,0.95 [0.88-1.03],0.1828834596190391
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,16791,308,0.94 [0.82-1.07],0.3410240894707274
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23314,41,1.24 [0.89-1.74],0.2043522686896646
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of liver,22868,141,0.76 [0.63-0.92],0.0053507864610405
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,22809,82,0.79 [0.61-1.01],0.0627505937846249
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22541,372,1.04 [0.93-1.17],0.5104277237717589
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,22440,271,1.07 [0.93-1.22],0.3522052405436603
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholecystitis,22238,69,1.11 [0.85-1.45],0.4326496078981323
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22201,32,1.22 [0.84-1.79],0.299184314586932
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22242,73,1.01 [0.78-1.30],0.96349055001012
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23512,73,1.00 [0.77-1.30],0.9883673005540076
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22335,323,1.02 [0.90-1.15],0.7818115252160919
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22049,37,0.99 [0.69-1.42],0.945079120663236
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Coeliac disease,22040,28,0.94 [0.62-1.43],0.767746170592189
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22073,61,1.22 [0.93-1.61],0.1552556052701803
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22242,230,0.97 [0.84-1.13],0.7122513804675272
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,GI-bleeding,22238,226,0.97 [0.83-1.12],0.6641685750262427
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20570,1492,0.97 [0.92-1.03],0.3557764533918587
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23261,94,1.03 [0.82-1.29],0.8050501279639188
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23324,451,0.95 [0.85-1.05],0.3304916568330589
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22104,461,0.96 [0.86-1.06],0.3995545902340969
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22706,463,0.97 [0.88-1.08],0.5903617688017768
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22348,105,0.94 [0.76-1.17],0.5891076850684067
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22542,299,0.99 [0.87-1.13],0.9136038780228471
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23441,92,0.94 [0.75-1.19],0.6189507972224779
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23427,78,0.99 [0.77-1.28],0.9641187071192228
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23407,58,1.05 [0.78-1.40],0.7482103741303721
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23391,59,0.91 [0.68-1.22],0.5394346609006375
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23389,57,nan [nan-nan],
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22930,57,0.91 [0.68-1.22],0.544386443468521
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23239,366,0.94 [0.84-1.06],0.2961186513828899
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21727,84,0.95 [0.74-1.21],0.6637011702995348
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21688,45,0.62 [0.44-0.88],0.0075936631582648
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21683,40,0.62 [0.43-0.90],0.0122323897732427
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21825,182,1.01 [0.85-1.19],0.9396335507749628
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21803,160,0.98 [0.82-1.17],0.7966836085592275
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17483,3546,1.02 [0.98-1.06],0.3532639260460994
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18968,2083,1.03 [0.97-1.08],0.3219632596913973
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21463,1071,1.03 [0.96-1.11],0.3766474802478629
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16970,85,1.33 [1.05-1.68],0.0162126520064051
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17293,408,1.07 [0.95-1.19],0.267992512262952
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23447,82,1.30 [1.03-1.65],0.0275917850015166
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23453,73,1.43 [1.12-1.83],0.004279405058784
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17947,1062,1.03 [0.96-1.11],0.3976862102130895
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",20379,1062,1.03 [0.96-1.10],0.4706840643433865
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17015,130,1.12 [0.92-1.36],0.2759492648481575
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22754,126,1.11 [0.91-1.35],0.322746552883375
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17051,166,0.93 [0.78-1.11],0.4282242899577514
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16940,55,0.94 [0.69-1.28],0.6906382765144357
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17141,256,1.05 [0.92-1.21],0.4681928856448849
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23583,121,1.09 [0.89-1.34],0.3920939320826001
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17455,570,1.04 [0.94-1.14],0.4389513076254239
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17185,300,0.97 [0.85-1.11],0.6591519888549198
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18038,1153,1.00 [0.93-1.07],0.9577119092851054
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16908,23,1.04 [0.65-1.65],0.8807532501149807
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16933,48,1.10 [0.80-1.52],0.545829451817297
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16915,30,1.22 [0.82-1.81],0.3349829650794217
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16900,15,1.09 [0.62-1.92],0.7669760353789794
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17478,593,1.01 [0.92-1.11],0.8048057774830325
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17404,519,1.02 [0.92-1.12],0.7020978233709518
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19133,256,0.96 [0.83-1.10],0.5579422927219391
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23416,33,0.98 [0.67-1.43],0.9000437311141596
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23399,16,1.01 [1.01-1.01],0.0
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20723,43,0.96 [0.68-1.35],0.8247775111549472
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20964,284,0.93 [0.82-1.07],0.314467653078493
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21505,825,0.99 [0.91-1.07],0.728322171343964
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20844,164,0.97 [0.81-1.16],0.744973965613682
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20771,91,0.91 [0.72-1.15],0.4424646878784222
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21320,640,1.01 [0.92-1.10],0.8526439096800218
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20730,50,1.03 [0.76-1.41],0.8423618180697605
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20905,225,1.07 [0.93-1.24],0.3452400804397527
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20778,98,1.05 [0.84-1.30],0.6890449727240715
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20744,64,0.90 [0.68-1.20],0.4825678401317108
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20800,120,1.08 [0.88-1.32],0.4780414274119718
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20731,51,0.95 [0.69-1.29],0.7345789106774896
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20937,257,1.04 [0.91-1.20],0.5561639713266103
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20626,234,1.09 [0.94-1.26],0.2364857993522234
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20456,64,1.18 [0.90-1.55],0.2343492311936104
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20455,63,1.06 [0.80-1.40],0.6798349557233117
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20452,60,1.14 [0.86-1.50],0.35262971942059
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20453,61,0.99 [0.75-1.31],0.9601345591400148
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20567,175,1.08 [0.91-1.28],0.3589796820509199
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20557,165,1.05 [0.88-1.24],0.6131783288623296
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20635,243,0.97 [0.84-1.12],0.6356822140960524
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20440,48,0.96 [0.70-1.32],0.8043788082631996
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20476,84,0.89 [0.69-1.14],0.3555128669746961
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20503,111,0.95 [0.77-1.18],0.6431751134893477
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20434,42,0.86 [0.61-1.22],0.4049474974952796
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20740,348,1.05 [0.94-1.19],0.3874876245438827
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20534,142,1.09 [0.90-1.31],0.3636186037567596
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20579,187,1.08 [0.92-1.27],0.3713961462792988
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22683,101,1.01 [0.81-1.26],0.9251787038289156
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22870,288,1.08 [0.95-1.23],0.2559851552889904
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22639,57,1.04 [0.78-1.39],0.7740878646636974
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22633,51,1.19 [0.88-1.60],0.2555174005043635
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22670,88,1.15 [0.92-1.45],0.2210522779209033
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18182,2369,1.01 [0.96-1.06],0.6879746031801368
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,20435,1277,0.99 [0.93-1.05],0.694953649497128
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,20906,307,1.08 [0.96-1.23],0.2101221242589143
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20693,94,0.92 [0.73-1.16],0.4825726809232937
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,20939,75,1.16 [0.90-1.49],0.2621017479657817
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,20956,92,1.21 [0.96-1.51],0.1075274392943427
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20957,93,1.04 [0.83-1.32],0.7119358901386772
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23212,362,1.03 [0.92-1.16],0.5728901203400579
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23173,79,1.49 [1.18-1.88],0.000883526306769
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23103,253,1.01 [0.88-1.16],0.8568695026662468
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22988,138,1.15 [0.95-1.38],0.1433908295337442
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21506,839,1.01 [0.93-1.09],0.881941809867802
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,20727,60,0.97 [0.72-1.30],0.8304475174974935
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20740,73,1.00 [0.77-1.29],0.9755559896313252
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21053,386,0.98 [0.87-1.10],0.7054020345246083
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20810,143,1.05 [0.87-1.26],0.6233188129653013
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21036,369,1.04 [0.93-1.17],0.4996405173823353
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19726,568,1.03 [0.93-1.13],0.5534245141836593
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19261,103,0.86 [0.69-1.08],0.2006988552195278
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19256,98,0.99 [0.79-1.24],0.9114118334950976
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19322,164,1.07 [0.90-1.27],0.4645012147976817
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19318,160,1.08 [0.90-1.28],0.4095100592208922
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19374,216,0.86 [0.74-1.01],0.0634600689342243
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23198,77,0.97 [0.75-1.25],0.8303223655768874
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21537,546,1.02 [0.93-1.12],0.6812753908614906
